Eliot Forster

Manufactures and markets recombinant therapeutic proteins

Manufactures and sells pharmaceutical products

Discovers and develops new drug candidates for the treatment & management of pain

Engages in discovery, development and preparation of bioavailable therapeutics

Operates as a biotechnology company

Develops novel bispecific antibody products

Operates as a biotechnology company

Functions as an investment holding company

Operates genomes project in research and health care for patients with cancer and rare diseases and their families

Develops treatments for osteoarthritis and chronic pain

MedCity Ltd. is a central organization dedicated to accelerating innovation, investment, and growth within the life sciences sector. The private company is based in Canterbury, UK. It supports a broad range of life sciences companies—including biotech, medtech, diagnostics, digital health, and advanced therapies—by providing expert guidance, tailored business growth services, and access to a network of investors, academia, industry, and the NHS. MedCity runs programs such as Grow, Health Accelerator for Social Enterprise, TechBio Boost, Collaborate to Innovate, and the Investment Hub, which offer accelerators, seed funding, pitch events, mentorship, and strategic partnerships to help SMEs scale, secure investment, and expand internationally. The organization facilitates connections between SMEs and a network of over 400 angel and venture capital investors, and offers a free brokerage service to help companies find R&D and manufacturing lab space across key life science clusters. MedCity provides resources including setup guides for companies relocating or investing, market intelligence reports, sector analyses, and updates on funding and regulatory developments. Through events and newsletters, MedCity keeps stakeholders informed and engaged, emphasizing collaboration across the ecosystem to foster innovation and raise awareness of the region as a life sciences hub.

Researches and develops oncology and immuno-oncology compounds

Manufactures pharmaceutical products

Develops antibody products to improve the treatment of serious diseases

Operates as a biopharmaceutical company that develops antibodies therapeutics for cancer therapy

Develops genomic medicines to rejuvenate donors livers

Engages in developing immunotherapies for cancer treatments

Operates as a biotech company that develops antibody therapeutics for cancer and other diseases

Operates as a biotechnology company which develops immunotherapies

Develops and commercializes transformative medicines for cancer, infection and autoimmune disease

Operates as a non profit organization that provides health care research services

Operates as a biotechnology company

Operates as a biotechnology company which develops therapeutic antibodies